Tedco awards $600K to tech firms - Nashville Business Journal:

showarticle-cultura.blogspot.com
The money was granted in collaboration withthe U.S. Army Medica Research and Materiel Commandf and the throughthe Ft. Detrick Technologyy Transfer Initiative. The purpose of the technologyu transfer program is to raise awareness of new and developing technologie s and funding them to transitiom as viable projectsfor follow-on funding in the market Each company that received funding was awarded approximatelhy $50,000 between March 2008 and May 2009, making up the initiative’ws second round of financial award s since its $750,000 program The funds for the program’s seconrd phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. R-Md. “The [Ft.
Detrici Technology Transfer Initiative] program is enabling area businessews to harness the technologiezs being developed at Fort Detrick and appl them to thecommercial sector,” said Mikulski. “Thias will lead to new products that have the powedr to create jobs andsave lives.” Mikulskji announced the first phase of the tech transfetr program in March 2005 when 11 companies receivedr funding. in Rockville: The company is developing a health care technologyt calledmiTag system, which is a scalable wireless sensot solution for improving patient flow. in The company is developing a technology called the GeNovaw Screento identify, isolate, and produce antibody-like molecules.
in Rockville: The companty is developing an on-demanx biotech products including a combination vaccin against plagueand anthrax. BioAssay Works LLC in The company is developinga lateral-flow visuapl diagnostic test to detect and differentiatr single sample multiple pathogenic poxviruses, includingf variola, vaccinia, and monkeypox. in Catonsville: The company is safety-testiny a medical product called ClotFoam, which is a non-compressible, intracavitary hemostatic agent.
CynerGend IDMP in Frederick: The company is developing, validatin g and implementing a supplemental diagnosisof Malaria, HIV, and Dengur using its Infectious Diseass Multiplex Panel approach, which could allos for creation of biosensors. LLC in The company is developing required components and system framewormk to enable conversational interfaces fortelemedicinee tools. Such tools would allos professional medics touse voice, gesture, and otherr human-- computer interactions to access and document information in electroni medical records. in Rockville: The company is developing technology to preserve mammalian cells in driex format that can easilybe re-hydrated for a varietgy of uses.
LLC in Frederick: The compangy is evaluating the effect of Imagilin patentecd probiotics as a food supplement to enhanc the immune responsiveness of guinea pigs upon immunizatiobn or challenge withvirulent pathogens. The evaluation will suggest the ability of Imagilin patented probiotics to enhance the immunizatio n ofa vaccine. in Baltimore: The compang is developing micropatterned substrates for virallinfectivity assays. Juxtopia in Baltimore: The company is customizinh its Wearable Assistance and SituationalkAwareness (WASA) goggles and servicr to allow U.S.
Army combat medics to access and documeng information to electrical medical recordsvia hands-free voice-requesta and voice-responses. in Baltimore: The companhy is developing cell therapies to treatt brain and spinalcord injuries.